BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29963520)

  • 1. Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis.
    El-Menshawy N; Abd-Aziz SM; Elkhamisy EM; Ebrahim MA
    Blood Res; 2018 Jun; 53(2):138-144. PubMed ID: 29963520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT.
    Kong Y; Xu LP; Liu YR; Qin YZ; Sun YQ; Wang Y; Jiang H; Jiang Q; Chen H; Chang YJ; Huang XJ
    Bone Marrow Transplant; 2015 Mar; 50(3):348-53. PubMed ID: 25486581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.
    Li XM; Zhang LP; Wang YZ; Lu AD; Chang Y; Zhu HH; Qin YZ; Lai YY; Kong Y; Huang XJ; Liu YR
    Leuk Res; 2016 Apr; 43():33-8. PubMed ID: 26930456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL.
    Kong Y; Wu YL; Song Y; Shi MM; Cao XN; Zhao HY; Qin YZ; Lai YY; Jiang H; Jiang Q; Huang XJ
    J Transl Med; 2017 Aug; 15(1):184. PubMed ID: 28854975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia-propagating cells demonstrate distinctive gene expression profiles compared with other cell fractions from patients with de novo Philadelphia chromosome-positive ALL.
    Zhao HY; Song Y; Cao XN; Qin YZ; Lai YY; Jiang H; Jiang Q; Huang XJ; Kong Y
    Ann Hematol; 2018 May; 97(5):799-811. PubMed ID: 29429020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kong Y; Chang YJ; Liu YR; Wang YZ; Jiang Q; Jiang H; Qin YZ; Hu Y; Lai YY; Duan CW; Hong DL; Huang XJ
    Leukemia; 2014 Dec; 28(12):2398-401. PubMed ID: 25135692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M
    Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic Significance of the Percentage of Blasts with CD34
    Xiang LL; Qiu GQ; Xie XB; Cen JN; Hu SY; Gu WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):61-65. PubMed ID: 28245376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CD34(+)CD19(+) cells with CD123 overexpression are a novel prognostic marker in Ph chromosome-positive acute lymphoblastic leukemia].
    Kong Y; Huang XJ; Hao L; Qin YZ; Jiang Q; Jiang H; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):6-10. PubMed ID: 24598641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
    Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
    Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio.
    Nagant C; Casula D; Janssens A; Nguyen VTP; Cantinieaux B
    Int J Lab Hematol; 2018 Dec; 40(6):734-739. PubMed ID: 30113764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.
    Vergez F; Green AS; Tamburini J; Sarry JE; Gaillard B; Cornillet-Lefebvre P; Pannetier M; Neyret A; Chapuis N; Ifrah N; Dreyfus F; Manenti S; Demur C; Delabesse E; Lacombe C; Mayeux P; Bouscary D; Recher C; Bardet V
    Haematologica; 2011 Dec; 96(12):1792-8. PubMed ID: 21933861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation.
    Jentzsch M; Bill M; Nicolet D; Leiblein S; Schubert K; Pless M; Bergmann U; Wildenberger K; Schuhmann L; Cross M; Pönisch W; Franke GN; Vucinic V; Lange T; Behre G; Mrózek K; Bloomfield CD; Niederwieser D; Schwind S
    Am J Hematol; 2017 Apr; 92(4):388-396. PubMed ID: 28133783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults].
    Chen HY; Ge Z; Wu YJ; Wu LY; Sun M; Tian T; Qiou HR; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):714-7. PubMed ID: 20561435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.
    Mustjoki S; Richter J; Barbany G; Ehrencrona H; Fioretos T; Gedde-Dahl T; Gjertsen BT; Hovland R; Hernesniemi S; Josefsen D; Koskenvesa P; Dybedal I; Markevärn B; Olofsson T; Olsson-Strömberg U; Rapakko K; Thunberg S; Stenke L; Simonsson B; Porkka K; Hjorth-Hansen H;
    Leukemia; 2013 Jul; 27(7):1520-6. PubMed ID: 23328954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Ann Hematol; 2001 Sep; 80(9):510-5. PubMed ID: 11669298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can CD34
    Stolpa W; Mizia-Malarz A; Zapała M; Zwiernik B
    Front Pediatr; 2023; 11():1213009. PubMed ID: 37675394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High proportion of CD34+/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
    Long J; Liu S; Li K; Zhou X; Zhang P; Zou L
    Leuk Lymphoma; 2014 Mar; 55(3):611-7. PubMed ID: 23706103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.